Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rare Diseases | 3 | 2024 | 629 | 1.330 |
Why?
|
| Neonatology | 3 | 2022 | 142 | 1.030 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2023 | 83 | 0.810 |
Why?
|
| Infant, Premature | 3 | 2022 | 2121 | 0.810 |
Why?
|
| Burnout, Professional | 2 | 2022 | 710 | 0.800 |
Why?
|
| Premature Birth | 2 | 2024 | 1830 | 0.740 |
Why?
|
| Minority Health | 1 | 2021 | 79 | 0.690 |
Why?
|
| Health Status Disparities | 3 | 2021 | 1878 | 0.640 |
Why?
|
| Faculty | 1 | 2022 | 383 | 0.640 |
Why?
|
| Healthcare Disparities | 4 | 2022 | 3407 | 0.610 |
Why?
|
| Mentors | 1 | 2022 | 671 | 0.550 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 606 | 0.500 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2022 | 858 | 0.490 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2015 | 83 | 0.480 |
Why?
|
| Genetic Testing | 3 | 2024 | 3594 | 0.460 |
Why?
|
| Karyotyping | 1 | 2015 | 1175 | 0.420 |
Why?
|
| Patient Participation | 1 | 2021 | 1447 | 0.390 |
Why?
|
| Language | 1 | 2021 | 1550 | 0.390 |
Why?
|
| Genomics | 2 | 2024 | 5925 | 0.330 |
Why?
|
| Critical Illness | 1 | 2022 | 2749 | 0.320 |
Why?
|
| Infant, Newborn | 9 | 2024 | 26380 | 0.300 |
Why?
|
| Genetic Variation | 1 | 2020 | 6612 | 0.240 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2015 | 1404 | 0.240 |
Why?
|
| Internship and Residency | 2 | 2022 | 5945 | 0.230 |
Why?
|
| Genetic Code | 1 | 2024 | 139 | 0.230 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5509 | 0.200 |
Why?
|
| Pandemics | 1 | 2021 | 8721 | 0.180 |
Why?
|
| Economics | 1 | 2021 | 141 | 0.170 |
Why?
|
| Community-Based Participatory Research | 1 | 2021 | 223 | 0.160 |
Why?
|
| Patient Discharge | 2 | 2022 | 3460 | 0.150 |
Why?
|
| Organizational Policy | 1 | 2021 | 434 | 0.150 |
Why?
|
| Infant | 5 | 2023 | 36426 | 0.150 |
Why?
|
| Humans | 22 | 2024 | 765926 | 0.150 |
Why?
|
| Curriculum | 2 | 2022 | 3784 | 0.140 |
Why?
|
| Peer Group | 1 | 2022 | 702 | 0.140 |
Why?
|
| Aftercare | 1 | 2022 | 915 | 0.130 |
Why?
|
| Empathy | 1 | 2020 | 474 | 0.130 |
Why?
|
| Residence Characteristics | 1 | 2024 | 2116 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2015 | 285 | 0.120 |
Why?
|
| Birth Weight | 1 | 2023 | 2122 | 0.120 |
Why?
|
| Pregnancy | 4 | 2024 | 30230 | 0.120 |
Why?
|
| Hematologic Tests | 1 | 2015 | 239 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2015 | 386 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1353 | 0.110 |
Why?
|
| Minority Groups | 1 | 2021 | 1208 | 0.110 |
Why?
|
| Research | 1 | 2021 | 1974 | 0.100 |
Why?
|
| Boston | 1 | 2024 | 9334 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2021 | 1949 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 7842 | 0.090 |
Why?
|
| Mothers | 1 | 2021 | 2206 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 39228 | 0.090 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 2969 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2022 | 3615 | 0.080 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 1775 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 2184 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2022 | 3928 | 0.080 |
Why?
|
| Health Policy | 1 | 2021 | 2699 | 0.080 |
Why?
|
| Female | 8 | 2024 | 396141 | 0.080 |
Why?
|
| Carboplatin | 1 | 2011 | 787 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 14745 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3796 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 5364 | 0.070 |
Why?
|
| Sleep | 1 | 2022 | 4818 | 0.070 |
Why?
|
| Health Personnel | 1 | 2020 | 3385 | 0.070 |
Why?
|
| Risk Factors | 2 | 2024 | 74850 | 0.060 |
Why?
|
| Pediatrics | 1 | 2020 | 3609 | 0.060 |
Why?
|
| Genome, Human | 2 | 2015 | 4443 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15401 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 16039 | 0.050 |
Why?
|
| Child | 2 | 2022 | 80568 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3661 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2020 | 24275 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 18074 | 0.040 |
Why?
|
| Adult | 2 | 2024 | 223088 | 0.040 |
Why?
|
| Young Adult | 1 | 2024 | 59857 | 0.040 |
Why?
|
| United States | 2 | 2023 | 72909 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 4904 | 0.030 |
Why?
|
| Data Collection | 1 | 2023 | 3318 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 81537 | 0.030 |
Why?
|
| Male | 2 | 2024 | 363815 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1881 | 0.020 |
Why?
|
| Disease Management | 1 | 2020 | 2530 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 4055 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 171163 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6503 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 15540 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9525 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 8603 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 17060 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12803 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 29890 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13631 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2011 | 65194 | 0.000 |
Why?
|
Concepts
(93)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_